参考文献/References:
[1] Liefaard LC, Ploeger BA, Molthoff CF, et al. Changes in GABAA receptor properties in amygdala kindled animals:In vivo studies using[11C]flumazenil and positron emission tomography. Epilepsia, 2009, 50(1):88-98. Epub 2008 Aug 25.
[2] Marini C, Harkin LA, Wallace RH, et al. Childhood absence epilepsy and febrile seizures:a family with a GABA (A) receptor mutation. Brain, 2003, 126(pt 1):230-240.
[3] Fedi M, Berkovic SF, Marini C, et al. A GABAA receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. Neuroimage, 2006, 32(3):995-1000.
[4] Zimmerman G, Njunting M, Ivens S, et al. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur J Neurosci, 2008, 27(4):965-975.
[5] Lipovsek M, Plazas P, Savino J, et al. Properties of mutated murine alphagbeta2 nicotinic receptors linked to partial epilepsy. Neurosci Lett, 2008, 434(2):165-169.
[6] Mohamed A, Eberl S, Fulham M J, et al. Sequential 123I-iododexetimde scans in temporal lobe epilepsy:comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging). Eur J Nucl Med Mol Imaging, 2005, 32(2):180-185.
[7] Picard F, Bruel D, Servent D, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients:a PET study. Brain, 2006, 129(Pt 8):2047-2060.
[8] Yu M, Tueckmantel W, Wang X, et al. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine:synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nucl Med Biol, 2005, 32(6):631-640.
[9] Severance AJ, Parsey RV, Kumar JS, et al. In vitro and in vivo evaluation of[11C]MPEPy as a potential PET ligand for mGlu5 receptors. Nucl Med Biol, 2006, 33(8):1021-1027.
[10] Bankstahl JP, Hoffmann K, Bethmann K, et al. Glutamate is critically involved in seizure-induced overexpression of Pglycoprotein in the brain. Neuropharmacology, 2008, 54(6):1006-1016.
[11] Surmeier DJ, Ding J, Day M, et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci, 2007, 30(5):228-235.
[12] Fedi M, Berkovic SF, Scheffer IE, et al. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy. Neurology, 2008, 71(11):795-798.
[13] Frost JJ. Receptor localization and quantification with PET. Radiology, 1988, 169(1):273-274.
[14] Hammers A, Asselin MC, Hinz R, et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain, 2007, 130(Pt 4):1009-1016.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[4]杨洋,樊赛军.LXXLL模体在雌激素受体信号通路中的作用及应用价值[J].国际放射医学核医学杂志,2014,38(1):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
Yang Yang,Fan Saijun.Role of LXXLL motif in modulation of estrogen receptor signaling and its potential application[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
[5]白庆双,李宁,方佩华,等.人血清TRAb酶联免疫吸附试验检测在甲状腺疾病患者中的临床应用[J].国际放射医学核医学杂志,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
Bai Qingshuang,Li Ning,Fang Peihua,et al.The clinical application of human serum level of the TRAb measured by enzyme-linked immunosorbent assay in patients with thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
[6]李丽,赵长久,田国梅.CXC型趋化因子受体4及其分子显像剂在肿瘤方面的研究进展[J].国际放射医学核医学杂志,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
Li Li,Zhao Changjiu,Tian Guomei.Research progress of CXC chemokine receptor type 4 and molecular imaging in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
[7]王晓慧,陈雪红,柳江燕,等.发作期SPECT脑血流灌注显像和VEEG在癫痫灶定位诊断中的一致性[J].国际放射医学核医学杂志,2014,38(6):368.[doi:10.3760/cma.j.issn.1673-4114.2014.06.005]
Wang Xiao-hui,Chen Xue-hong,Liu Jiang-yan,et al.The consistency of ictal SPECT and VEEG studies in localizing the epileptic focus[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):368.[doi:10.3760/cma.j.issn.1673-4114.2014.06.005]
[8]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[9]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[10]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[11]侯敏.癫痫的PET受体显像[J].国际放射医学核医学杂志,2003,27(4):168.
HOU Min.Receptor imaging by PET in epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):168.